Hints from the skin beneath: Vitiligo in Vogt-Koyanagi-Harada disease

被引:2
|
作者
Lim, Jo Anne [1 ]
Tan, Wooi Chiang [2 ]
Nor, Norazirah Md [3 ]
机构
[1] Univ Sains Malasia, Hosp USM, Sch Med Sci, Dept Internal Med, Gelugor, Kelantan, Malaysia
[2] Hosp Pulau Pinang, Dept Dermatol, George Town, Malaysia
[3] Univ Kebangsaan Malaysia, Fac Med, Kuala Lumpur, Malaysia
关键词
Autoimmune disease; uveitis; vitiligo; Vogt-Koyanagi-Harada disease; NIVOLUMAB ANTI-PD-1 ANTIBODY; PROGNOSTIC-FACTORS; UVEITIS; MELANOMA; IPILIMUMAB; DIAGNOSIS; REVERSAL; OUTCOMES;
D O I
10.4103/ds.ds_23_22
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Vogt-Koyanagi-Harada disease (VKHD) is a major vision-threatening autoimmune disease. One of its associated features is vitiligo. Little study has been done on the association between vitiligo and the disease activity of VKHD. The authors searched available literature on the relationship between vitiligo and ophthalmic disease activity in VKHD in terms of pathogenesis, clinical presentations, risk factors as well as disease activity. Among the findings is that early treatment of VKHD may be associated with full recovery. The reversal of poliosis and vitiligo is associated with the remission of uveitis, but the reverse does not hold true, whereby the worsening of vitiligo may not reflect the worsening of uveitis. It is also found that there may be an association between immunotherapy and Vogt-Koyanagi-Harada-like disease. In summary, vitiligo is an immune-mediated cutaneous manifestation which may contribute to diagnostic and treatment strategies in VKHD. Future research on genetic differences in vitiligo is still needed and may contribute to specific monitoring and therapeutic approach in this disease.
引用
收藏
页码:78 / +
页数:9
相关论文
共 50 条
  • [1] Inflammatory vitiligo in Vogt-Koyanagi-Harada disease
    Tsuruta, D
    Hamada, T
    Teramae, H
    Mito, H
    Ishii, M
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2001, 44 (01) : 129 - 131
  • [2] VITILIGO AND THE VOGT-KOYANAGI-HARADA SYNDROME
    BARNES, L
    DERMATOLOGIC CLINICS, 1988, 6 (02) : 229 - 239
  • [3] Vitiligo as a First Sign of Vogt-Koyanagi-Harada Disease
    Vukojevit, Marija
    Vukojevic, Nenad
    Vukovic, Ante
    Rupcic, Borna
    Blazevic, Mislav
    Blazevic, Ante
    ACTA DERMATOVENEROLOGICA CROATICA, 2023, 31 (04) : 229 - 231
  • [4] Successful Treatment of Vitiligo Associated with Vogt-Koyanagi-Harada Disease
    Bayer, Michelle L.
    Chiu, Yvonne E.
    PEDIATRIC DERMATOLOGY, 2017, 34 (02) : 204 - 205
  • [5] Vogt-Koyanagi-Harada disease
    Bonnet, C.
    Daudin, J. -B.
    Monnet, D.
    Brezin, A.
    JOURNAL FRANCAIS D OPHTALMOLOGIE, 2017, 40 (06): : 512 - 519
  • [6] Vogt-Koyanagi-Harada disease
    Ortiz Balbuena, Jorge
    Tutor de Ureta, Pablo
    Rivera Ruiz, Esther
    Mellor Pita, Susana
    MEDICINA CLINICA, 2016, 146 (02): : 93 - 94
  • [7] Vogt-Koyanagi-Harada disease
    O'Keefe, Ghazala A. Datoo
    Rao, Narsing A.
    SURVEY OF OPHTHALMOLOGY, 2017, 62 (01) : 1 - 25
  • [8] Vogt-Koyanagi-Harada Disease
    Tugal-Tutkun, Ilknur
    Smit, Derrick P.
    Abu El-Asrar, Ahmed M.
    Herbort Jr, Carl P.
    Thorne, Jennifer E.
    OCULAR IMMUNOLOGY AND INFLAMMATION, 2024, 32 (04) : 363 - 366
  • [9] Reversal of Poliosis and Vitiligo Following Vogt-Koyanagi-Harada Disease
    Tabbara, Khalid F.
    ARCHIVES OF OPHTHALMOLOGY, 2012, 130 (03) : 394 - 396
  • [10] Vogt-Koyanagi-Harada disease
    Street, Duncan
    Sivaguru, Arul
    Sreekantam, Sreekanth
    Mollan, Susan P.
    PRACTICAL NEUROLOGY, 2019, 19 (04) : 364 - 367